Dhingra S,Vir D,Bakshi J,Rishi P .2022 .Mapping of audiometric analysis with microbiological ndings in patients chronic suppurative otitis media (CSOM): A neglected clinical manifestation. Crit Rev in Clin Lab Sci, 2158173(3) : 212-32.
Panday A,Rathore VS,Naku A .2024 .Assessment of bacterio-logical causes of CSOM and to know their antibiotic sensitivity pattern. Int J Life Sci Biotechnol Pharma, 111(7) : 593-7.
Heward E,Saeed H,Bate S,Rajai A,Molloy J,Isba R .2024 .Risk factors associated with the development of chronic suppurative otitis media in children: Systematic review and meta analysis. Clin Otolaryngol, 10(1) : 62-73.
Bhatia R,Singh M,Pradhan P. .2022 .Trends in health equity and access among children with otitis media in India: A systematic review. J Pediatr Pulmonol, 23(3) : 22-92.
Jespersen SI,Demant MN,Pedersen ML,Homoe P .2020 .Acute otitis media and pneumococcal vaccination an observational cross-sectional study of otitis media among vaccinated and unvaccinated children in Greenland. Int J Circumpolar Health, 1858615(1) : 1858615.
Gupta A,Thai A,Maria PLS .2024 .Epidemiology of chronic suppurative otitis media in the United States. Ann Oto Rhinol Laryngol, 10(8) : 741-9.
Wei Y,Sun D,Jaiswal S,He Y,Liu X,Wang Ja X .2024 .Association of lifestyle with valvular heart disease progression and life expectancy among elderly people from di erent socioeconomic backgrounds. BMC Med, 10(1) : 367.
Popescu C,Varut RM,Puticiu M,Belghiru VI,Banicioiu M,Rotaru LT .2024 .Comprehensive management of cholesteatoma in otitis media: Diagnostic challenges, imaging advances, and surgical outcome. J Clin Med, 10(22) : 6791.
Xu J,Du Q,Shu Y,Ji J,Dai C .2021 .Bacteriological pro le of chronic suppurative otitis media and antibiotic susceptibility in a tertiary care hospital in Shanghai, China. Ear Nose Throat J, 10(9) : NP391-6.
Suttle TK,Els T,Toman J,Curtis D,McNab R,Sizemore A .2024 .Chronic suppurative otitis media: A prospective descriptive study of the microbiology and antimicrobial susceptibility patterns. Otolaryngol Head and Neck Surg, 10(1) : 90-7.
Adejobi A,Ojo O,Alaka O,Odetoyin B,Onipede A .2021 .Antibiotic resistance pattern of Pseudomonas spp. from patients in a tertiary hospital in South-West Nigeria. Germs, 1260(2) : 238-45.
Khan I,Osama M,Ullah I,Haq IU .2025 .Microbiological spectrum and antibiotics sensitivity pattern of chronic suppurative otitis media (CSOM) patients: A prospective study from a Tertiary Care Hospital in Peshawar. Pak J Med Sci, 10(1) : 194-9.
Anwar S,Ahmed SA,Nigar I,Khan RR,Setu SK,Sattar ANI .2024 .l Analysis of the current bacteriological pro le and antibiotic susceptibility patterns of organisms isolated from aural swabs in a Tertiary Care Hospital in Dhaka, Bangladesh. Fortune J Health Sci, 10 : 615-22.
Iqbal N,Anwar S,Salim S,Tehseen T,Ali S,Raza A .2024 .Antibiogram of chronic suppurative otitis media in relation to the current bacteriological pro le in a tertiary care hospital. Infect Dis J Pak, 10(2) : 298-73.
Khatun MR,Alam KMF,Naznin M,Salam MA .2021 .Microbiology of chronic suppurative otitis media: An update from a tertiary care hospital in Bangladesh. Pak J Med Sci, 10(3) : 8216.
Nee M,Kimita W,Waldvogel-Thurlow S .2025 .Host microbe interactions in healthy and CSOMa ected middle ears. Microorganisms, 10(2) : 339.
Nosair N,Elzayat S,Elsharaby R,Abdulgha ar IA,Elfarargy HH,Sharaf NA .2024 .The association of bacterial bio lm middle ear mucosa in patients with mucosal chronic suppurative otitis media. Acta Otorrinolaringol Esp, 02(4) : 244-51.
Marin A,Semenescu A,Dinu S,Poenaru M .2022 .Bacteria, bio lm and cholesteatoma-perspectives of innovative therapeutic approaches. Med Evol, 10(3) : 1057-27.
Agha ZHM,Al-Delaimi MS .2021 .Prevalence of common bacterial etiology and antimicrobial susceptibility pattern in patients with otitis media in Duhok Province Iraq. Zanco J Pure Appl Sci, 33(4) : 11-25.
Prakash R,Juyal D,Negi V,Pal S,Adekhandi S,Sharma M .2013 .Microbiology of chronic suppurative otitis media in a tertiary care setup of Uttarakhand state. India. N Am J Med Sci, 10(4) : 110436.
Zamudio R,Hijazi K,Joshi C,Aitken E,Oggioni MR,Gould IM .2019 .Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic brosis patients. Int J Antimicrob Agents, 02(6) : 774-80.
Daikos GL,da Cunha CA,Rossolini GM,Stone GG,BaillonPlot N,Tawadrous M .2021 .Review of ceftazidime-avibactam for the treatment of infections caused byPseudomonas aeruginosa. Antibiotics, 10(9) : 1126.
Corbella L,Boan J,San-Juan R,Fernandez-Ruiz M,Carretero O,Lora D .2021 .E ectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa. Int J Antimicrob Agents, 106517(2) : 106517.